| 時間 | 主題 | ||
|---|---|---|---|
11:15 ~ 11:19 |
Prognostic impact of EVITA and adverse events in advanced urothelial carcinoma treated with enfortumab vedotin
講者:
Satoru Taguchi
座長:
Taigo Kato, Chi-Ping Huang |
Satoru Taguchi |
Taigo Kato, Chi-Ping Huang |
11:19 ~ 11:23 |
Geriatric nutritional risk index as a practical biomarker for survival and severe anemia in locally advanced or metastatic UC treated with enfortumab vedotin
講者:
Taku NAIKI
座長:
Chi-Ping Huang, Taigo Kato |
Taku NAIKI |
Chi-Ping Huang, Taigo Kato |
11:23 ~ 11:27 |
Real-world outcomes of ICI-based combination therapies in clear cell and nonclear cell renal cell carcinoma
講者:
Tomohiro Inoue
座長:
Taigo Kato, Chi-Ping Huang |
Tomohiro Inoue |
Taigo Kato, Chi-Ping Huang |
11:27 ~ 11:31 |
Balancing oncologic safety and perioperative burden: Is kidney-sparing surgery a viable option for frail patients with high-grade UTUC?
講者:
Cheng-Han Chang
座長:
Taigo Kato, Chi-Ping Huang |
Cheng-Han Chang |
Taigo Kato, Chi-Ping Huang |
11:31 ~ 11:35 |
Prospective randomized comparison of fulldose vs low-dose SII-Onco-BCG in NMIBC
講者:
Wei Tu
座長:
Taigo Kato, Chi-Ping Huang |
Wei Tu |
Taigo Kato, Chi-Ping Huang |
11:35 ~ 11:39 |
Deferred cytoreductive nephrectomy following pembrolizumab plus lenvatinib therapy for advanced RCC
講者:
Yuta Ogushi
座長:
Taigo Kato, Chi-Ping Huang |
Yuta Ogushi |
Taigo Kato, Chi-Ping Huang |
11:39 ~ 11:43 |
Initial experience with single-port robotic radical nephroureterectomy and bladder cuff resection
講者:
Yun-Ching Su
座長:
Taigo Kato, Chi-Ping Huang |
Yun-Ching Su |
Taigo Kato, Chi-Ping Huang |
11:43 ~ 11:47 |
Extent, pattern, and reconstruction drive bypass use in renal cancer-associated IVC tumor thrombus surgery
講者:
Yi-Hao Lin
座長:
Taigo Kato, Chi-Ping Huang |
Yi-Hao Lin |
Taigo Kato, Chi-Ping Huang |